Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Firms / Archimed

Archimed

Buyout firmUpper middle marketLyonarchimed.groupSEC exempt reporting adviser

ARCHIMED is a global investment firm focused on driving the sustainable development of healthcare industries.

Classification
Class
Buyout firmconfirmed, confidence 85%
Basis
R6: 13 of 13 distinct vehicles are sworn Private Equity Funds; 13 reported gross assets on a filing in 2022 or later
Size band
Upper middle marketdefined by: proxy: $7.00bn Private Equity Fund GAV on the Form ADV filed 2024-03-19
Classification history (1)
  1. Sep 13, 2026
    Buyout firm (confirmed, 85%, cls-pe-1)
    R6: 13 of 13 distinct vehicles are sworn Private Equity Funds; 13 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
Adviser type
exempt reporting adviser
Form ADV filings
Jul 20, 2018 to Mar 19, 2024
RAUM
unknownregulatory assets under management of the adviser; not dry powder, not a fund size
PE funds, latest filing
13
PE fund GAV, latest filing
$7.0Breported gross assets (Form ADV), not fund size
All private fund GAV
$7.0Bevery private fund type, latest filing
2024 PE fund GAV
$7.0Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
PE share of funds, lifetime
100%
Fund type mix
filed 2024-03-19, latest gav Private Equity Fund $7.0B, latest counts Private Equity Fund 13, lifetime distinct Private Equity Fund 13
Employees
unknown
Headquarters
Lyon, France
Office address
9 RUE DES CUIRASSIERS, Lyon, 69003
Business phone
0033 481 11 3533
Stated criteria beside observed behaviour
3 observed deals
Stated by the firm
Sectors
healthcare, financial services
Geography
Global, North America, Europe, Asia
Revenue
not stated or not yet read
EBITDA
not stated or not yet read
Enterprise value
not stated or not yet read
Equity check
not stated or not yet read
Control
not stated or not yet read
Thesis
Through our various fund lines, we invest between 10 million and 1 billion euros in leading companies, always backing the corresponding management teams.
Observed from deals on record
roles
unknown 1, minority 1, platform 1
period
to 2026-08-19, from 2026-04-29, undated holdings 1, dated observations 3
window
last 2026-04-29, first 2026-04-29
control
control 1, unknown 1, minority 1
companies
3
geography
investments
3
seller kinds
transactions
1
cadence by year
2026 platforms 1
platform add on
add ons 0, platforms 1, add ons per platform unknown
sector known for
1
disclosed value usd
n 0
sector distribution
count 1, share 0.333, value healthcare it, examples Ametris
holding period years
n 0
repeat counterparties
subsector distribution
count 1, share 0.333, value healthcare it, examples Ametris

3 companies on the graph (1 transactions); most in healthcare it (1); 1 platforms and 0 add-ons; observed 2026 to 2026

Funds
14 on record
FundVehicleVintageReported gross assets (Form ADV), not fund sizeGAV by yearForm D soldLifecycle
MED Platform II B Fpci
ADV: Private Equity Fund
buyout or unlabelled2024
first reported on Form ADV
$237M
as of Mar 19, 2024
no Form DUnknown
MED III B
ADV: Private Equity Fund
Feeder or parallel2024
first reported on Form ADV
$144M
as of Mar 19, 2024
no Form DUnknown
Mpii Slp + Mpii B
ADV: Private Equity Fund
Feeder or parallel2023
first reported on Form ADV
$3.1B
as of Mar 19, 2024
no Form DEarly deployment
MED III
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$575M
as of Mar 19, 2024
no Form DUnknown
Mpii Coi Nmi Slp
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$492M
as of Mar 19, 2024
no Form DUnknown
Mpi-Coi- Suan S.L.P.
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$196M
as of Mar 19, 2024
no Form DEarly deployment
MED 1
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$161M
as of Mar 19, 2024
no Form DEarly deployment
Mpi-Coi-Carso S.L.P.
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$158M
as of Mar 19, 2024
no Form DEarly deployment
Mpi-Coi-Prollenium S.L.P.
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$119M
as of Mar 19, 2024
no Form DEarly deployment
MEP Platform I S.L.P.
ADV: Private Equity Fund
buyout or unlabelled2021
first reported on Form ADV
$1.1B
as of Mar 19, 2024
no Form DUnknown
Polymed
ADV: Private Equity Fund
buyout or unlabelled2021
first reported on Form ADV
$196M
as of Mar 19, 2024
no Form DUnknown
Mpi-Coi-Namsa S.L.P.
ADV: Private Equity Fund
buyout or unlabelled2021
first reported on Form ADV
$193M
as of Mar 19, 2024
no Form DActive deployment
MED II S.L.P.
ADV: Private Equity Fund
buyout or unlabelledunknown$348M
as of Mar 19, 2024
no Form DSuccessor fundraising
Archimed MED IVbuyout or unlabelledunknownunknownno reportingno Form DUnknown
Team
23 current, 2 former
Partner (18)
2 former (kept with end dates)
  • Andre-Michel Ballester · Delegate Managing Director · Sep 1, 2018 to Mar 19, 2024 Inference
  • Benoit Adelus · Delegate Managing Director · Sep 1, 2018 to Mar 31, 2021 Inference
Portfolio
3 relationships, 1 platforms, 0 add-ons
CompanyRoleStatusInvestedHeldPartnerSource
Renata MedicalMinorityactiveAug 19, 2026
venture round
1 monthsunknownFact DFX graph bridge (shared CRD, CIK, EIN, SEC fund id and individual CRD across fo/isi/vc/pe)
La CaissePlatformactiveApr 29, 2026
transaction announcement
5 monthsunknownFact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
AmetrisRole unknownexited
exited Sep 9, 2026
unknownunknownunknownFact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
Transactions
2 on record
DateTypeTargetThis firm’s roleSource
Sep 9, 2026Exit to a strategic buyerAmetrisSeller (confirmed)archimed.group
Apr 29, 2026Platform acquisitionLa CaisseSponsor (confirmed)archimed.group
Placement agents, lenders, advisers and co-investors
2 relationships
Placement agents (2)
  • Triago 4 shared · strong · last Jan 1, 2023
  • Triago Uk Limited 2 shared · recurring · last Jan 1, 2021
LP commitments
1 disclosed
  • Teachers' Retirement System of the State of Illinois amount not disclosed trsil.org
Events
10 most recent
  1. Sep 13, 2026
    ARCHIMED closes MED IV fund at €1.5 billion ($1.75 billion) hard cap, three times oversubscribed, in less than six months of fundraising.
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  2. Sep 9, 2026
    ARCHIMED Healthcare IT sells global digital health solutions provider Ametris to Signant Health
    ExitFactAmetrisPress release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
  3. Sep 9, 2026
    ARCHIMED Life Science Tools & Services acquires IRAB, a leading independent radiopharmaceuticals platform
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  4. Sep 9, 2026
    ARCHIMED Healthcare IT sells global digital health solutions provider Ametris to Signant Health
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  5. Sep 9, 2026
    ARCHIMED Diagnostics acquires Stago, a global leader in blood coagulation analysis
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  6. Sep 9, 2026
    ARCHIMED Successfully Completes Take-private of Esperion Therapeutics
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  7. Apr 29, 2026
    ARCHIMED Diagnostics acquires Stago, a global leader in blood coagulation analysis
    Platform investmentFactLa CaissePress release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
  8. Mar 31, 2026
    Archimed: Private Equity Funds on Form ADV 13 (2024 extract) -> 18 (roster 2026-09-01)
    Pe fund count changedFactSEC Form ADV monthly roster (registered + exempt reporting advisers)
  9. Jun 2, 2025
    Teachers' Retirement System of the State of Illinois reports ArchiMed SAS: an undisclosed amount committed
    Lp commitment disclosedFactTeachers' Retirement System of the State of IllinoisPublic pension private-markets disclosures, read through the venture lane's LP report tape
  10. Jul 20, 2018
    Archimed first filed Form ADV in the extract (ERA)
    First Form ADV filingFactSEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Across the graphs

Archimed is the same institution as 2 records in Venture Capital and Allocators.

Venture Capital1Allocators1

Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.

Checking your plan…